AVNTAvient Corporation
Is it growing?
Growing: earnings up +45% year on year and operating margin widening (+1.2 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −5% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 9.3% now against 8.0% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is AVNT growing?
Avient Corporation has grown revenue 0.48% a year over three years and −5.1% a year over five, with earnings per share compounding at −33%.
Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · growing slowly · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- −5.1%
Revenue growth, 5-year rate · +0.48% over three · growth has picked up over the last three years
- Earnings per share, 3-year rate
- −33%
Earnings per share, 3-year rate · revenue +0.48% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 17
Years of annual history on file · FY2009 to FY2025, as filed
Details›
- Revenue FY2021
- $3.32B
- Revenue FY2022
- $3.40B
- Revenue FY2023
- $3.14B
- Revenue FY2024
- $3.24B
- Revenue FY2025
- $3.26B
Annual income statements as filed with the SEC.
Specialty Chemicals
Ranks #16 of 33 by RyuScore